| 名稱 | hIL9 Effector Reporter Cell |
| 型號(hào) | CBP74207 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | hIL9 Effector Reporter Cell |
產(chǎn)品搜索
相關(guān)文章
- FLT3標(biāo)準(zhǔn)品簡(jiǎn)介
- 【新品上線】多重病原菌質(zhì)控品
- ?LILRB4細(xì)胞篩選模型
- MicroRNA或可特異性地殺死攜帶常見突變的癌細(xì)胞
- 人類白細(xì)胞抗原HLA基因分型標(biāo)準(zhǔn)品
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- 實(shí)驗(yàn)?zāi)芊裰貜?fù)仍在持續(xù)：誰來給韓春雨事件畫上句號(hào)？
- 選擇本公司的人結(jié)腸癌細(xì)胞株有3個(gè)理由
- 一箭雙雕——IL-4R靶點(diǎn)和IL-4/IL-13雙重阻斷藥篩細(xì)胞模型
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74207hIL9 Effector Reporter Cell
- 詳細(xì)內(nèi)容
hIL9 Effector Reporter Cell
| I. Background | |
| IL9 (Interleukin 9) is a Protein Coding gene. Diseases associated with IL9 include Severe Combined Immunodeficiency, X-Linked and Trichuriasis. Among its related pathways are Apoptotic Pathways in Synovial Fibroblasts and MIF Mediated Glucocorticoid Regulation. | |
| II.Introduction | |
| Expressed gene: | IL9R |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10%DMSO |
| Culture Medium: | DMEM+10%FBS+2μg/ml Puromycin+100μg/ml Hygromycin B+5μg/ml Blasticidin+400μg/ml G418 |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
Figure 1. Recombinant hIL9 Effector Reporter Cell constitutively expressing CD132.
Figure 2. Recombinant hIL9 Effector Reporter Cell constitutively expressing IL9R. | |
Figure 3. Dose Response of Recombinant Human IL9 in hIL9 Effector Reporter Cells (C18) | |
Figure 4.Inhibition of Human IL9-induced Reporter Activity by hIL9 Neutralization Ab in hIL9 Effector Reporter Cells (C18). | |
會(huì)員_a.png)